← Leaderboards
Michael Phillip Dube
Indiana University Indianapolis
$1,045,908
Attributed
$1,739,500
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $741.1K · FY2008–20$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,739,500 · 9
By mechanism
R01$1,387,185 · 1
R21$243,000 · 1
M01$109,315 · 7
Top collaborators
- Ronald J. Ellis2 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Mark Sebastian Sulkowski$12,713,668
- Matthias Clauss$8,411,925
Others in their field
Top investigators on “Source”
- Richard A Gibbs · Baylor College Of Medicine$285,393,445
- David Heimbrook · Leidos Biomedical Research, Inc.$233,184,481
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Jeffrey P Krischer · University Of South Florida$224,745,020
- Albert Lazzarini · California Institute Of Technology$202,317,285
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$155,571,437
Research focus
SourceUnited States National Institutes Of HealthResourcesComputer Retrieval Of Information On Scientific Projects DatabaseGrantFundingInstitutionResearch PersonnelFutureRandomizedAntiretroviral TherapyAffectBlood VesselsFatty Acid Glycerol EstersHiv-1ResponseEnrollmentPharmaceutical PreparationsBloodAnti-Retroviral AgentsLdl Cholesterol LipoproteinsInflammationBaseLink
Grant awards (10)
Phase II trial of tesamorelin for cognition in aging HIV-infected persons$741,150
R01 · FY2020 · AG
Phase II trial of tesamorelin for cognition in aging HIV-infected persons$646,035
R01 · FY2019 · AG
Microbial Translocation and HIV-Related Endothelial Dysfunction$243,000
R21 · FY2010 · AI · contact PI
EFFECT OF HIV-1 PROTEASE INHIBITORS ON ENDOTHELIAL FUNCTION AND GLUCOSE$64,060
M01 · FY2008 · RR · contact PI
CROSS-SECTIONAL AND LONGITUDINAL STUDY OF ENDOTHELIAL FUNCTION BY BRACHIAL FLOW-$35,892
M01 · FY2008 · RR · contact PI
SWITCH TO ATAZANAVIR AND BRACHIAL ARTERY REACTIVITY (SABAR) STUDY: ENDOTHELIA$4,770
M01 · FY2008 · RR · contact PI
A PILOT STUDY OF THE SAFETY, EFFICACY, AND TOLERABILITY OF EZETIMIBE (ZETIA?)$1,818
M01 · FY2008 · RR · contact PI
PLAN FOR OBTAINING INFORMED CONSENT TO USE STORED HUMAN BIOLOGICAL MATERIALS$1,363
M01 · FY2008 · RR · contact PI
A PHASE II/III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF URIDINE$1,136
M01 · FY2008 · RR · contact PI
PILOT STUDY TO ESTABLISH THE USE OF BRACHIAL ULTRASOUND TO MEASURE VASCULAR R$276
M01 · FY2008 · RR · contact PI